CMSA has conducted capital mar­kets awareness programs to various targeted groups including, youth of different calibres.

NEW YORK — Akero Ther­a­peu­tics may not have ad­e­quate da­ta for ac­cel­er­at­ed ap­proval of its MASH drug, de­spite show­ing it may re­verse cir­rho­sis in pa­tients with … ...

This article compares two productivity suites, Microsoft Office 2021 and Office 2024, focusing on key differences in features, system requirements, pricing models, and support lifecycles.

in the obe­si­ty space has ac­cel­er­at­ed since the ap­proval of We­govy in June 2021. To date, the largest obe­si­ty deal has been Roche’s ac­qui­si­tion of Car­mot Ther­a­peu ...